Changing desire, sleep and concentration deserve a care conversation. Read a clinician's argument alongside menopause guidance and its limits.
On October 28, 2026, Newsweek published physician Dr. Gail King's argument that “normal for your age” should begin a conversation about symptoms rather than close it. Her commentary focuses on sleep, memory and sexual health, which she says deserve attention even when changes may be associated with aging.
The point is not that every midlife change signals a medical problem. It is that reassurance should follow consideration of possible causes rather than take its place. For readers concerned about desire, that leaves room for a useful question: what explains this particular change?
King's Newsweek contribution is professional commentary based on her practice observations and recommendations. Its focus is women bringing questions about hormones and symptoms into medical appointments. It is not a study following an enrolled group over a defined period.
The other sources informing this discussion have different purposes. The American Medical Association (AMA) published an explanatory feature featuring an obstetrician and gynecologist. The American College of Obstetricians and Gynecologists (ACOG) announced menopause-management recommendations. The World Health Organization (WHO) published a discussion focused on early menopause and the need for better research and guidance.
These sources provide a framework for understanding clinical conversations rather than a single set of experimental results. King's proposal is about what deserves attention during an appointment. The accompanying guidance helps place that proposal within a broader approach to assessment and care decisions.
King recommends asking routinely about disrupted sleep, difficulty concentrating and changes in sexual desire. Her argument shifts the responsibility away from waiting for patients to introduce potentially sensitive subjects themselves.
That matters to the structure of an appointment. If sexual wellbeing is included among ordinary health questions, a patient does not have to decide whether it is important enough to mention separately. King's recommendation is to make room for the subject, then consider the person's history and the nature of the change.
The AMA feature adds clinical context. In it, OB/GYN Elizabeth Lapeyre identifies low libido, vaginal dryness and pain with intercourse among symptoms that may be associated with menopause. She also describes sleep problems and brain fog, alongside hot flashes and night sweats.
This places sexual concerns within the broader health conversation rather than treating them as an unrelated side issue. It also keeps different experiences visible: a change in desire is not the same description as dryness or pain. Naming the concern more precisely gives the discussion a clearer starting point.
King's article describes menopause as identified retrospectively after 12 consecutive months without a menstrual period. Perimenopause precedes it and postmenopause follows it. For background on this transition, Sexential's resource on changing symptoms and needs around perimenopause provides further educational context.
King says she has heard more women in their early 40s asking about hormones in her practice. She explicitly cautions that this observation does not establish a national trend. It should not be used to claim that women across the country are seeking care differently.
Symptoms also do not establish their own cause. King warns against using menopause as a catch-all explanation for midlife changes. Her recommendation is to consider the history and whether another explanation needs investigation, rather than replacing dismissal with an equally automatic hormone explanation.
WHO notes that symptoms and their intensity differ among women. Its discussion also focuses specifically on early menopause. That scope matters when applying its broader message about recognition to the wider midlife population.
The testing advice requires similar precision. Newsweek reports that women over 45 with menopausal symptoms usually do not need hormone tests to diagnose menopause. That does not mean testing is never appropriate or that other investigations are unnecessary. The statement concerns a particular diagnostic question, not every possible reason for ordering a test.
These distinctions preserve the value of the central argument. Taking a concern seriously means considering it carefully, not promising that one explanation or investigation will settle it.
King's argument fits with the AMA's October 6, 2026 feature on whether midlife changes reflect aging or menopause. Lapeyre advises consulting a clinician familiar with menopause to help distinguish hormone-related changes from other causes. The shared emphasis is on explanation through clinical discussion.
ACOG's October 15, 2026 announcement addresses a related but different stage: decisions about managing symptoms. It recommends shared decision-making about hormone therapy that considers symptoms and medical history. Baseline health risks, treatment goals and patient priorities also belong in that discussion.
Recognition and treatment choice are therefore separate questions. A concern about desire can deserve attention without committing someone to hormone therapy. Acknowledging a symptom is the start of understanding it, while selecting treatment involves a more individual conversation.
That distinction is useful when reading coverage of how menopause guidance frames care choices. The presence of recommendations does not remove the need to discuss what matters to the person considering care.
WHO's October 2026 discussion adds another point of agreement. It warns that menopause's effects may be dismissed as inevitable aging and calls for better research and global guidance on early menopause. This supports King's concern about recognition without turning her observations into population-level evidence.
Read together, these sources place attention and assessment alongside each other. The choice is not between dismissing symptoms and assuming that menopause explains them. There is room for a more useful response: acknowledge the experience, examine the context and discuss the reasoning behind care decisions.
For readers, the practical value is a clearer way to describe concerns and understand the response. King's recommendations support bringing desire into the same conversation as sleep or concentration. They do not require a reader to arrive with a diagnosis already in mind.
A useful discussion can include the following questions:
These are conversation prompts rather than a diagnostic checklist. Decisions about investigations or treatment belong with a qualified healthcare professional who can consider the individual's circumstances. Readers wanting help organizing their concerns can also read about clarifying priorities before a menopause-care visit.
King also acknowledges practical constraints. In her account, short appointments and competing demands can leave questions unanswered. A follow-up may create more time, but she notes that it can also bring financial and practical burdens. Her argument is not that patients should carry all the work of making a sensitive subject discussable.
If the answers received do not address the concern, King explicitly recommends seeking another opinion. That option is about getting an unresolved question considered, rather than securing a predetermined answer about hormones or treatment.
The phrase “normal for your age” can sound like a closing statement. King's commentary offers a different use for it: a starting point for asking what has changed and what deserves attention. The more useful endpoint is not simply reassurance, but reassurance with an explanation the person can understand.
A concern about midlife libido deserves attention without an automatic hormone explanation, and Sexential treats that distinction as an educational question. Its calm coverage of desire and arousal connects biology with everyday intimacy for adults aged 35 to 65 who want less confusion about sexual changes, without assigning a diagnosis or selecting treatment.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A Medscape review of women’s responses after orgasm puts a 117-participant study in context, without making continued activity an expectation.
A large Epic Research review raises questions about repeat testing before testosterone prescriptions. Learn how the findings fit diagnostic guidance.
A 51-participant study linked estrogen plus testosterone to higher spine-density scores. See how the finding fits menopause guidance and sexual health.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
